Pancreatitis, ENdoscopic transGastric versUs primary necrosectomy in patients with Infected Necrosis
ISRCTN | ISRCTN07091918 |
---|---|
DOI | https://doi.org/10.1186/ISRCTN07091918 |
Secondary identifying numbers | N/A |
- Submission date
- 11/12/2006
- Registration date
- 28/03/2007
- Last edited
- 21/03/2012
- Recruitment status
- No longer recruiting
- Overall study status
- Completed
- Condition category
- Digestive System
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Plain English summary of protocol
Not provided at time of registration
Contact information
Dr Robin Timmer
Scientific
Scientific
St Antonius Hospital
Department of Gastroenterology
P.O. Box 2500
Nieuwegein
3402 EM
Netherlands
r.timmer@antonius.net |
Study information
Study design | Randomised controlled multicentre observer-blinded trial |
---|---|
Primary study design | Interventional |
Secondary study design | Randomised controlled trial |
Study setting(s) | Hospital |
Study type | Treatment |
Scientific title | Pancreatitis, ENdoscopic transGastric versUs primary necrosectomy in patients with Infected Necrosis: a randomised controlled multicentre observer-blinded trial (Dutch Acute Pancreatitis Study Group) |
Study acronym | PENGUIN |
Study objectives | Endoscopic transgastric necrosectomy will lead to a reduction of the pre- and post-operative pro-inflammatory response, as compared to necrosectomy by laparotomy, in patients with infected (peri-)pancreatic necrosis. |
Ethics approval(s) | Regional Medical Ethics Board for the Meander Medical Centre Amersfoort-Baarn-Soest (De Verenigde Commissies Mensgebonden Onderzoek [VCMO]) approved on the 17th April 2007 (ref: LTME/VL-07.08) |
Health condition(s) or problem(s) studied | Acute necrotising pancreatitis |
Intervention | Endoscopic transgastric necrosectomy or necrosectomy by laparotomy, followed by continuous post-operative lavage |
Intervention type | Other |
Primary outcome measure | Pro-inflammatory response as measured by the maximum increase in level of serum cytokine Interleukin six (IL-6) in the period between start of the first necrosectomy and five hours thereafter |
Secondary outcome measures | 1. Complications (bleeding, perforation, pancreatic fistula, pancreatic pseudocyst requiring intervention, pancreatic abscess requiring intervention, biliary strictures, incisional hernia requiring re-intervention and pancreatic insufficiency) 2. Mortality 3. Total number of interventions 4. Total hospital stay 5. Total intensive care stay |
Overall study start date | 01/03/2007 |
Completion date | 01/03/2009 |
Eligibility
Participant type(s) | Patient |
---|---|
Age group | Adult |
Lower age limit | 18 Years |
Sex | Not Specified |
Target number of participants | 20 |
Key inclusion criteria | 1. Age equal to or above 18 years 2. Pancreatic necrosis or peripancreatic necrosis detected on contrast-enhanced computed tomography (CECT) 3. Patients in whom a decision for surgical intervention has been made because of (suspected) infected (peri-)pancreatic necrosis 4. Safe access route for endoscopic transgastric necrosectomy 5. Written informed consent |
Key exclusion criteria | 1. Participation in another intervention trial that would interfere with the intervention and outcome of this study 2. Previous surgical necrosectomy for (suspected) infected pancreatic necrosis, including procedures performed in referring hospitals. Previous percutaneous or transgastric drainage is allowed 3. Previous exploratory laparotomy for acute abdomen and diagnosis of pancreatitis during laparotomy 4. Acute flare-up of chronic pancreatitis 5. Bleeding, abdominal compartment syndrome or perforation of a visceral organ as indication for intervention 6. Post-abdominal surgery necrotising pancreatitis |
Date of first enrolment | 01/03/2007 |
Date of final enrolment | 01/03/2009 |
Locations
Countries of recruitment
- Netherlands
Study participating centre
St Antonius Hospital
Nieuwegein
3402 EM
Netherlands
3402 EM
Netherlands
Sponsor information
St Antonius Hospital Nieuwegein (Netherlands)
Hospital/treatment centre
Hospital/treatment centre
Department of Gastroenterology
P.O. Box 2500
Nieuwegein
3402 EM
Netherlands
Website | http://www.antonius.net/rood/english.php |
---|---|
https://ror.org/01jvpb595 |
Funders
Funder type
Hospital/treatment centre
University Medical Centre Utrecht (UMCU) (Netherlands)
No information available
Results and Publications
Intention to publish date | |
---|---|
Individual participant data (IPD) Intention to share | No |
IPD sharing plan summary | Not provided at time of registration |
Publication and dissemination plan | Not provided at time of registration |
IPD sharing plan |
Study outputs
Output type | Details | Date created | Date added | Peer reviewed? | Patient-facing? |
---|---|---|---|---|---|
Results article | results | 14/03/2012 | Yes | No |